Innovation During COVID-19 Townhall: Progress Towards COVID-19 Therapeutics
Date and Time
Wednesday Jul 22, 2020
1:00 PM - 2:30 PM EDT
July 22
1:00 - 2:30 p.m.
Location
Webinar
Fees/Admission
Please click here to RSVP to the event.
Dial-in information will be shared with those who RSVP on
Tuesday, July 21st.
Website
Contact Information
Hosted by PhRMA
Description
America’s biopharmaceutical companies’ have acted quickly to focus their expertise on treatments for COVID-19. Currently, treatments being tested range from antiviral and antibody therapies to anticoagulant and antimicrobial therapies – to target both the virus itself and the most dangerous health consequences of COVID-19.
Please join PhRMA member company executives for a townhall on COVID-19 therapeutic development – a unique forum to hear directly from leaders in the fight to beat COVID-19, including:
- Ramona Sequeira, President, Takeda
- David Ricks, Chairman and Chief Executive Officer, Eli Lilly and Company
- Alexander Hardy, Chief Executive Officer, Genentech
- Johanna Mercier, Chief Commercial Officer, Gilead
